Clinical Trials Logo
  1. Home
  2. Low Grade Glioma
  3. NCT02197637

Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma — OVIMA-1210  

Low-Grade Glioma Clinical Trial

Official title:
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma

Clinical Trial Summary

The purpose of this study is to determine whether oral vinorelbine is effective in the treatment of children with progressive or recurrent unresectable low grade glioma.

Clinical Trial Description

The aim of this study is to determine efficacy of oral vinorelbine in children with progressive or recurrent unresectable low grade glioma, in addition to safety, pharmacokinetic, pharmacogenetic, medical costs and quality of life. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02197637
Study type Interventional
Source Centre Oscar Lambret
Contact
Status Completed
Phase Phase 2
Start date May 2014
Completion date October 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04734444 - SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue N/A
Recruiting NCT01837862 - A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas Phase 1/Phase 2
Recruiting NCT06104488 - A Study of Avutometinib for People With Solid Tumor Cancers Phase 1
Completed NCT04659421 - Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade Gliomas Phase 2
Recruiting NCT04174820 - Child's Study of the Impact of PF Lesion on Motor Skills, Language, Cognitive Functioning and Social Cognition
Completed NCT05373394 - Evaluation of Cognitive and Motor Neurological Disorders in the Short and Long Term After Surgery for the Removal of a Diffuse Low-grade Glioma of the Supplementary Motor Area
Recruiting NCT05406700 - Niraparib In Recurrent IDH 1/2 Gliomas Early Phase 1
Active, not recruiting NCT04865315 - A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors
Recruiting NCT06159478 - Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume) Phase 2
Recruiting NCT06381570 - Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas Early Phase 1
Terminated NCT03763422 - Trial in Low Grade Glioma Patients: Wait or Treat Phase 3
Completed NCT04346472 - Longitudinal MRI Assessment in Patients With Diffuse Low-grade Gliomas
Active, not recruiting NCT03948490 - Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas N/A
Recruiting NCT04923126 - SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma Phase 1/Phase 2
Completed NCT00782626 - Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas Phase 2
Completed NCT05873946 - Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery
Not yet recruiting NCT05555550 - Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG Early Phase 1
Withdrawn NCT05233215 - GROW (Glioma Specialists Reaching Out With Support) Support N/A
Completed NCT01497860 - Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas Phase 2
Recruiting NCT05566795 - DAY101 vs. Standard of Care Chemotherapy in Pediatric Patients With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) Phase 3